UBS raised the firm’s price target on Xometry (XMTR) to $35 from $33 and keeps a Neutral rating on the shares. Demand remained strong in Q1 and the company raised its 2025 revenue outlook, the analyst tells investors in a research note.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XMTR: